The Department of Energy is offering a technology licensing opportunity for AirWave, a novel respiratory therapy solution developed by Los Alamos National Laboratory. This technology utilizes personalized sound vibrations to effectively clear mucus from the lungs, providing a non-invasive treatment option for patients suffering from respiratory conditions such as COVID-19, pneumonia, and chronic lung diseases. The AirWave system is designed for use in various healthcare settings, including hospitals, pulmonary rehabilitation centers, and home healthcare, with significant commercial potential for medical device manufacturers and telehealth companies. Interested parties can reach out to Satya Srinivasan or Lindsay Augustyn at licensing@lanl.gov for further information, as the technology is currently at TRL 3 and is patent pending.